603309 维力医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)5.7624.18611.85210.87210.088
总资产报酬率 ROA (%)3.6522.6788.0577.7177.377
投入资产回报率 ROIC (%)4.1883.1379.3418.9248.512

边际利润分析
销售毛利率 (%)43.33644.73744.53345.88943.192
营业利润率 (%)16.7397.99917.59017.21115.158
息税前利润/营业总收入 (%)18.8319.13817.57017.46314.896
净利润/营业总收入 (%)14.0455.34115.13714.74413.038

收益指标分析
经营活动净收益/利润总额(%)96.557208.97096.72796.498101.525
价值变动净收益/利润总额(%)1.4922.5112.7793.6282.914
营业外收支净额/利润总额(%)-0.492-0.146-0.934-0.647-0.486

偿债能力分析
流动比率 (X)1.7351.5171.6661.8532.082
速动比率 (X)1.3311.2201.3491.5281.741
资产负债率 (%)34.28637.89333.00629.49327.012
带息债务/全部投入资本 (%)23.29123.05319.56816.44613.192
股东权益/带息债务 (%)312.279315.057394.699489.571635.190
股东权益/负债合计 (%)190.364162.533201.041236.488267.743
利息保障倍数 (X)8.6597.939123.55748.163-79.067

营运能力分析
应收账款周转天数 (天)47.31746.40647.34736.58329.876
存货周转天数 (天)80.25271.41967.00773.36877.007